Heart attack drug shows promise in reducing damage
Disease control
Completed
This study tested whether a medicine called henagliflozin can reduce the size of heart damage and improve heart function in people who had a severe heart attack. 248 adults took the drug or a placebo for 6 months after a procedure to open blocked arteries. Researchers measured he…
Phase: PHASE4 • Sponsor: Qian geng • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC